JP6134953B2 - 炎症及び酸化ストレスに対するアクロコミア・クリスパ及びアクロコミア・アクレアタ（ａｃｕｌｅａｔａ）の果実由来化合物 - Google Patents

炎症及び酸化ストレスに対するアクロコミア・クリスパ及びアクロコミア・アクレアタ（ａｃｕｌｅａｔａ）の果実由来化合物 Download PDF

Info

Publication number
JP6134953B2
JP6134953B2 JP2015517603A JP2015517603A JP6134953B2 JP 6134953 B2 JP6134953 B2 JP 6134953B2 JP 2015517603 A JP2015517603 A JP 2015517603A JP 2015517603 A JP2015517603 A JP 2015517603A JP 6134953 B2 JP6134953 B2 JP 6134953B2
Authority
JP
Japan
Prior art keywords
acid
patent document
acreata
composition
crispa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2015517603A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015521606A (ja
Inventor
カナヴァシオロ，ビクトル ルイス ゴンザレス
カナヴァシオロ，ビクトル ルイス ゴンザレス
ペレス，ロクサーナ，デ ラ カリダッド シエラ
ペレス，ロクサーナ，デ ラ カリダッド シエラ
フェレイロ，ロサ マリア マス
フェレイロ，ロサ マリア マス
ゲラ，ヨハニ ペレス
ゲラ，ヨハニ ペレス
イエラ，アンバー オイアルザバル
イエラ，アンバー オイアルザバル
レイエス，エドゥアルド アントニオ ロドリゲス
レイエス，エドゥアルド アントニオ ロドリゲス
クエバス，ヴィヴィアン モリーナ
クエバス，ヴィヴィアン モリーナ
メネンデス，ラファエル ガメス
メネンデス，ラファエル ガメス
Original Assignee
セントロ ナショナル デ インヴェスティゲーションズ シエンティフィカス（セーエネイーセー）
セントロ ナショナル デ インヴェスティゲーションズ シエンティフィカス（セーエネイーセー）
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48876979&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6134953(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by セントロ ナショナル デ インヴェスティゲーションズ シエンティフィカス（セーエネイーセー）, セントロ ナショナル デ インヴェスティゲーションズ シエンティフィカス（セーエネイーセー） filed Critical セントロ ナショナル デ インヴェスティゲーションズ シエンティフィカス（セーエネイーセー）
Publication of JP2015521606A publication Critical patent/JP2015521606A/ja
Application granted granted Critical
Publication of JP6134953B2 publication Critical patent/JP6134953B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Birds (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2015517603A 2012-06-19 2013-06-17 炎症及び酸化ストレスに対するアクロコミア・クリスパ及びアクロコミア・アクレアタ（ａｃｕｌｅａｔａ）の果実由来化合物 Expired - Fee Related JP6134953B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CUP2012000097A CU24143B1 (es) 2012-06-19 2012-06-19 Ingrediente activo para el tratamiento y la prevención de la inflamación y el estrés oxidativo, así como su procedimiento de obtención a partir de los frutos de acrocomina crispa y/o acrocomia aculeata
CUCU-2012-0097 2012-06-19
CUCU/P/2012/000097 2012-06-19
PCT/CU2013/000003 WO2013189467A2 (es) 2012-06-19 2013-06-17 Compuestos a partir de los frutos de acrocomia crispa y acrocomia aculeata contra la inflamación y el estrés oxidativo

Publications (2)

Publication Number Publication Date
JP2015521606A JP2015521606A (ja) 2015-07-30
JP6134953B2 true JP6134953B2 (ja) 2017-05-31

Family

ID=48876979

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015517603A Expired - Fee Related JP6134953B2 (ja) 2012-06-19 2013-06-17 炎症及び酸化ストレスに対するアクロコミア・クリスパ及びアクロコミア・アクレアタ（ａｃｕｌｅａｔａ）の果実由来化合物

Country Status (19)

Country Link
US (1) US20150190358A1 (enExample)
EP (1) EP2862567B1 (enExample)
JP (1) JP6134953B2 (enExample)
KR (1) KR102145079B1 (enExample)
CN (1) CN104684544A (enExample)
AU (1) AU2013279850A1 (enExample)
BR (1) BR112014031826A2 (enExample)
CA (1) CA2876907A1 (enExample)
CO (1) CO7240409A2 (enExample)
CU (1) CU24143B1 (enExample)
DK (1) DK2862567T3 (enExample)
ES (1) ES2648489T3 (enExample)
IL (1) IL236282A0 (enExample)
IN (1) IN2014DN10888A (enExample)
MX (1) MX361904B (enExample)
NO (1) NO20150088A1 (enExample)
PH (1) PH12014502817B1 (enExample)
PT (1) PT2862567T (enExample)
WO (1) WO2013189467A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4082518A1 (en) * 2021-04-28 2022-11-02 Cnce Innovacion, S.L. Fatty acid compositions for the treatment and prevention of hair loss and alopecia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB191412621A (en) * 1914-05-22 1915-08-05 Armenak Haroutune Suzmeyan Method and Process to Obtain Oil and Glucose from Nuts and Shells.
GB191512621A (en) * 1915-09-02 1916-09-04 John Arthur Torrens Improvements in or relating to Carburetters for Internal Combustion Engines.
CU23256A1 (es) * 2003-03-20 2008-01-24 Dalmer Lab Sa EXTRACTO OBTENIDO A PARTIR DE FRUTOS DE ROYSTONEA REGIA UTILIZADO CONTRA LA HIPERPLASIA PROSTáTICA Y LA PROSTATITIS
WO2006078848A1 (en) * 2005-01-21 2006-07-27 Western Holdings, Llc Compositions containing botanical extracts rich in phlorizin and methods for using such compositions in blood glucose modification and to affect aging

Also Published As

Publication number Publication date
NO20150088A1 (en) 2015-01-19
DK2862567T3 (da) 2017-11-06
IN2014DN10888A (enExample) 2015-09-11
US20150190358A1 (en) 2015-07-09
PH12014502817A1 (en) 2015-02-23
AU2013279850A1 (en) 2015-01-29
CU20120097A7 (es) 2014-01-29
MX361904B (es) 2018-12-19
KR20150029710A (ko) 2015-03-18
WO2013189467A2 (es) 2013-12-27
IL236282A0 (en) 2015-02-26
WO2013189467A3 (es) 2014-02-20
KR102145079B1 (ko) 2020-08-31
MX2014015774A (es) 2015-11-16
EP2862567A2 (en) 2015-04-22
ES2648489T3 (es) 2018-01-03
EP2862567B1 (en) 2017-07-26
JP2015521606A (ja) 2015-07-30
CA2876907A1 (en) 2013-12-27
CN104684544A (zh) 2015-06-03
CU24143B1 (es) 2016-01-29
PH12014502817B1 (en) 2015-02-23
BR112014031826A2 (pt) 2017-06-27
PT2862567T (pt) 2017-11-27
CO7240409A2 (es) 2015-04-17

Similar Documents

Publication Publication Date Title
CN102108318B (zh) 一种鳄鱼油脂及其制备方法和用途
JP2016534982A (ja) トケイソウ種子由来脂質抽出物
KR20180078344A (ko) 기난드로프시스 기난드라 또는 클레오메 기난드라 지상부위 추출물, 및 이를 포함하는 화장, 피부과학적 또는 약학조성물
JP6688492B2 (ja) 黒生姜含有ＰＰＡＲγ発現促進組成物
JP6055667B2 (ja) コラーゲン産生促進剤
CN106572967A (zh) 包含植物提取物的美白活性剂、其用途以及包含所述美白活性剂的组合物
JP6134953B2 (ja) 炎症及び酸化ストレスに対するアクロコミア・クリスパ及びアクロコミア・アクレアタ（ａｃｕｌｅａｔａ）の果実由来化合物
FR2875701A1 (fr) Nouvelle utilisation cosmetique ou dermatologique de lignanes
JP6773362B2 (ja) 経口摂取又は投与用皮膚保湿剤
JP6447972B2 (ja) 黒生姜含有ＰＰＡＲγ発現促進組成物
JP2011201785A (ja) 抗肥満剤
WO2021106856A1 (ja) 尿路機能改善用組成物及び膀胱血流改善用組成物
JP2000290189A (ja) 抗アレルギー剤
CN119969583B (zh) 一种缓解抑郁的组合物及其制备方法和应用
JP4836418B2 (ja) 抗酸化剤、抗炎症剤、美白剤及び皮膚化粧料
CN103877152A (zh) 含有石榴籽油和紫苏籽油的组合物、其制备方法和用途
EP4494647A1 (fr) Extrait d akènes de silybum marianum (l.) gaertn. pour le traitement ou la prévention de rougeurs cutanées
JP2005325034A (ja) 一重項酸素消去剤
KR101316398B1 (ko) 장어 추출물을 유효성분으로 함유하는 염증성 질환 예방 또는 치료용 조성물
KR100833220B1 (ko) 곽향 추출물을 함유하는 여드름 질환의 예방 및 치료용조성물
KR20130031008A (ko) 홍마늘 추출물을 포함하는 염증성 질환의 예방 또는 치료용 조성물
JP2014118349A (ja) プロスタグランジンｅ２産生抑制剤
KR20190112667A (ko) 미분화 형태의 n-팔미토일-d-글루코사민
JP2010105975A (ja) ヤマブドウ由来の腫瘍発生抑制剤
JP2017088616A (ja) 黒生姜含有組成物

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150514

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160331

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160517

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160905

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161202

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170302

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170403

R150 Certificate of patent or registration of utility model

Ref document number: 6134953

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees